Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frameshift Genomics is a specialized bioinformatics software company that develops infrastructure for the management, analysis, and visualization of large-scale genomic data. The company's flagship platform, Mosaic, is designed to facilitate collaborative genomic research by providing tools for variant calling, pedigree analysis, and clinical reporting. Founded by experts from the Broad Institute and Palantir, Frameshift focuses on bridging the gap between raw sequencing data and actionable clinical insights. The company was acquired by Seven Bridges (now part of Velsera) to integrate its advanced visualization and data management capabilities into a broader multi-omic ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frameshift.